Fox Chase Cancer Center: Carcinoma, Non-Small-Cell Lung trials

The registry lists 20 Carcinoma, Non-Small-Cell Lung studies with Fox Chase Cancer Center as lead sponsor. 2 are open to participants now and 5 have results posted.

Early Phase 1 1Phase 1 3Phase 2 12Phase 3 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung CancerNot yet recruitingNCT07854769
• Dose Attenuated Chemotherapy in Compromised Patients With Lung CancerRecruitingNCT05800587Phase 2
• Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 TherapyTerminatedNCT03302247Phase 2Results posted
• Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung CancerTerminatedNCT02963610Phase 1/2Results posted
• Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerTerminatedNCT02132884Not applicableResults posted
• Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00553800Phase 2Results posted
• Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00043108Phase 2Results posted
• Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLCWithdrawnNCT05400577Phase 2
• Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With PembrolizumabWithdrawnNCT04677361Early Phase 1
• Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLCActive, not recruitingNCT03786692Phase 2
• Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLCActive, not recruitingNCT03527108Phase 2
• Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle AspirateCompletedNCT03311620Not applicable
• Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung CancerCompletedNCT01840150Not applicable
• Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor CareCompletedNCT01726296Not applicable
• Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung CancerTerminatedNCT01471964Phase 1/2
• Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01059552Phase 1
• Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung CancerCompletedNCT00315185Phase 2
• Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWithdrawnNCT00054392Phase 3
• Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00039507Phase 2
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung CancerCompletedNCT00021333Phase 2